Blood pressure and the global burden of cardiovascular disease

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 543-552

  Rodgers, A ^a   MacMahon, S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antihypertensive drugs; Blood pressure; Coronary heart disease; Epidemiology; Population; Stroke

Indexed keywords

ASIA; CARDIOVASCULAR DISEASE; CHINA; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DISABILITY; HUMAN; HYPERTENSION; MORTALITY; POPULATION RESEARCH; UNITED KINGDOM; UNITED STATES;

EID: 0032765751     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909060987     Document Type: Conference Paper

References (15)

1. Murray CJL, Lopez AD. The Global Burden of Disease. Cambridge: Harvard University Press, 1996. (Murray CJL, Lopez AD, eds. Global Burden of Disease and Injury Series; vol 1).
2. Eastern Stroke and Coronary Heart Disease Collaborative Group. Blood pressure, cholesterol and stroke in Eastern Asia. The Lancet (in press) 1998.
3. Boedhi-Darmojo R, Setianto B, Sutedjo, Kusmana D, Andradi, Supari F, Salan R. A study of baseline risk factors for coronary heart disease: results of population screening in a developing country. Revue d Epidemiologie et de Sante Publique 1990;38(5-6):487-91.
4. World Health Organisation MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Statistics Quarterly 1988;41:115-40.
5. Wu Y, Yao C, Wu Z, Zhang R, Zhang M, Wu G, Zhao D, Hong Z. Interim report of Sino-MONICA-Beijing for the years 1985-1989. Chinese Medical Sciences Journal 1992;7(3):125-9.
6. Gupta R, Al-Odat NA, Gupta VP. Hypertension epidemiology in India: meta-analysis of 50 year prevalence rates and blood pressure trends. Journal of Human Hypertension 1996;10:465-72.
7. Schork NJ, Weder AB, Schork MA. On the asymmetry of biological frequency distributions. Genetic Epidemiology 1990;7:427-46.
8. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 45,000 people in 45 prospective cohorts. The Lancet 1995;346:1647-53.
9. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. Journal of Vascular Medicine and Biology 1994;4:265-71.
10. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JT, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. The Lancet 1997;350:757-64.
11. Strachan D, Rose G. Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease. Journal of Clinical Epidemiology 1991 ;44:1187-96.
12. Cook NR, Cohen J, Hebert P, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Archives of Internal Medicine 1995;155:701-9.
13. Jamison DT. Foreword to The Global Burden of Disease and Injury Series. In: Murray CJL, Lopez AD, eds. The Global Burden of Disease. Cambridge: Harvard University Press, 1996:
14. Mooney G, Irwig L, Leeder S. Priority setting in health care - unburdening from the burden of disease. Australian & New Zealand Journal of Public Health 1997;21:680-1.
15. Murray CJL, Lopez AD. Global patterns of cause of death and burden of disease in 1990, with projections to 2020. Investing in Health Research and Development. Report of the ad hoc committee on health research relating to future intervention options. Geneva: World Health Organisation, 1996: